Anemia

>

Latest News

AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease | Image Credit: US Food and Drug Administration
AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease

October 25th 2024

On October 25, 2024, Kind Pharmaceutical announced receipt of FDA Orphan Drug Designation for AND017 in the treatment of sickle cell disease.

Anemia Notably Impacts Heart Failure Prognosis, Study Finds| Image Credit: Fotolia
Anemia Notably Impacts Heart Failure Prognosis, Study Finds

October 14th 2024

Cognitive Dysfunction Common in Patients with Sickle Cell Anemia | Image Credit: Jan Krivec/Unsplash
Cognitive Dysfunction Common in Patients with Sickle Cell Anemia

October 14th 2024

Social Determinants of Health Shape Pain Outcomes in Sickle Cell Disease| Image Credit: Towfiqu barbhuiya/Unsplash
Social Determinants of Health Shape Pain Outcomes in Sickle Cell Disease

October 8th 2024

Iron Therapy Underutilized in Post-Kidney Transplant Anemia, Study Finds | Image Credit: LinkedIn
Iron Therapy Underutilized in Post-Kidney Transplant Anemia, Study Finds

October 7th 2024

<123456
© 2024 MJH Life Sciences

All rights reserved.